Metformin as a Possible Intervention for Cardiometabolic Risks in Pediatric Subjects Exposed to Antipsychotic Drugs

Andrade, Chittaranjan

doi:10.4088/jcp.16f11196

Search citation statements

Order By: Relevance

Paper Sections

Select...

Metformin In Psychiatry1

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

2024

Publication Types

Select...

Article4

Relationship

Self Cite1

Independent3

Authors

Journals

Cited by 4 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…6,7 Psychiatrists who advise metformin therefore need to be aware about important common and uncommon adverse effects of the drug. This article specifically examines gastrointestinal adverse effects of metformin, the risk of lactic acidosis with metformin, and possible vitamin B 12 deficiency associated with long-term use of metformin.…”

Section: Metformin In Psychiatrymentioning

confidence: 99%

Use of Metformin for Cardiometabolic Risks in Psychiatric Practice: Need-to-Know Safety Issues

Andrade

2016

J. Clin. Psychiatry

Self Cite

View full text Add to dashboard Cite

Section: Metformin In Psychiatrymentioning

confidence: 99%

Use of Metformin for Cardiometabolic Risks in Psychiatric Practice: Need-to-Know Safety Issues

Andrade

2016

J. Clin. Psychiatry

Self Cite

View full text Add to dashboard Cite

“…The same framework can be extended in the setting of SGA-induced obesity. While there are several studies and reviews encompassing adjunctive pharmacologic management of MetS in youth, to our knowledge, there have been no reviews combining the specific pathophysiology of SGA-related MetS and patient-centered lifestyle interventions [ 8 , 9 , 10 , 11 ]. Non-pharmacologic interventions for MetS in youth is the focus of our paper.…”

Section: Introductionmentioning

confidence: 99%

Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics

Rice

Ramtekkar

2020

Medical Sciences

View full text Add to dashboard Cite

Weight gain and metabolic syndrome are common side effects of second-generation antipsychotics and carry significant health consequences both in childhood and into adulthood. This review highlights evidence-based, non-pharmacologic interventions to assist in the management of these side effects. Such intervention categories include dietary, physical activity, sleep, stress management, and nutritional supplementation. Interventions with the highest quality evidence include increasing the consumption of fruits, vegetables, and whole grains, increasing physical activity, improving sleep, and fish oil supplementation. We suggest that clinicians work with patients on managing metabolic side effects in a patient-centered way, incorporating principles of motivational interviewing, to reduce the risk of metabolic syndrome.

show abstract

Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study

Nakhla,

Nair,

Balani

et al. 2024

Cardiovasc Drugs Ther

View full text Add to dashboard Cite

Metformin as a Possible Intervention for Cardiometabolic Risks in Pediatric Subjects Exposed to Antipsychotic Drugs

Cited by 4 publications

References 15 publications

Use of Metformin for Cardiometabolic Risks in Psychiatric Practice: Need-to-Know Safety Issues

Use of Metformin for Cardiometabolic Risks in Psychiatric Practice: Need-to-Know Safety Issues

Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics

Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study

Contact Info

Product

Resources

About